Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke in the National US GWTG-Stroke Population

被引：0
|
作者：
Saver, Jeffrey L. [1 ]
Fonarow, Gregg C. [1 ]
Smith, Eric E. [2 ]
Reeves, Mathew J. [3 ]
Grau-Sepulveda, Maria V. [4 ]
Pan, Wenqin [4 ]
Olson, DaiWai [4 ]
Hernandez, Adrian F. [4 ]
Peterson, Eric D. [4 ]
Schwamm, Lee H. [5 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Univ Calgary, Calgary, AB, Canada
[3] Michigan State Univ, E Lansing, MI 48824 USA
[4] Duke Clin Rsch Inst, Durham, NC USA
[5] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
STROKE | 2013年 / 44卷 / 02期
关键词：
Thrombolysis; Emergency care; Stroke; Fibrinolytic agents;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Time to Treatment With Endovascular Reperfusion Therapy and Outcome From Acute Ischemic Stroke in the National US GWTG-Stroke Population
    Jahan, Reza
    Saver, Jeffrey L.
    Schwamm, Lee H.
    Fonarow, Gregg C.
    Liang, Li
    Matsouaka, Roland A.
    Xian, Ying
    Peterson, Eric D.
    Yavagal, Dileep
    Smith, Eric E.
    [J]. STROKE, 2019, 50
  • [2] Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke
    Saver, Jeffrey L.
    Fonarow, Gregg C.
    Smith, Eric E.
    Reeves, Mathew J.
    Grau-Sepulveda, Maria V.
    Pan, Wenqin
    Olson, DaiWai M.
    Hernandez, Adrian F.
    Peterson, Eric D.
    Schwamm, Lee H.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (23): : 2480 - 2488
  • [3] Utilization of intravenous tissue plasminogen activator for acute ischemic stroke
    Katzan, IL
    Hammer, MD
    Hixson, ED
    Furlan, AJ
    Abou-Chebl, A
    Nadzam, DM
    [J]. ARCHIVES OF NEUROLOGY, 2004, 61 (03) : 346 - 350
  • [4] Update on Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
    Fugate, Jennifer E.
    Rabinstein, Alejandro A.
    [J]. MAYO CLINIC PROCEEDINGS, 2014, 89 (07) : 960 - 972
  • [5] Acute ischemic stroke: improving access to intravenous tissue plasminogen activator
    Turner, Ashby C.
    Schwamm, Lee H.
    Etherton, Mark R.
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (05) : 277 - 287
  • [6] Safety and efficacy of intravenous tissue plasminogen activator in acute ischemic stroke
    Rajapa, S.
    Sivakumar, S.
    Arjundas, D.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 133 - 133
  • [7] The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke
    Kahn, JH
    Viereck, J
    Kase, C
    Jeerakathil, T
    Romero, R
    Mehta, SD
    Kociol, R
    Babikian, V
    [J]. JOURNAL OF EMERGENCY MEDICINE, 2005, 29 (03): : 273 - 277
  • [8] Treatment with Intravenous Tissue Plasminogen Activator in the "Golden Hour" in the National US Get With The Guidelines-Stroke Population
    Saver, Jeffrey L.
    Fonarow, Gregg C.
    Smith, Eric E.
    Reeves, Mathew J.
    Navalkele, Digvijaya
    Grotta, James C.
    Grau-Sepulveda, Maria
    Hernandez, Adrain F.
    Peterson, Eric D.
    Schwamm, Lee H.
    [J]. STROKE, 2015, 46
  • [9] Tissue plasminogen activator for acute ischemic stroke
    Qureshi, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (21): : 1406 - 1406
  • [10] Intravenous tissue-type plasminogen activator for the treatment of acute ischemic stroke: The Spanish registry
    Davalos, A
    Alvarez-Sabin, J
    Marti-Vilalta, JL
    Castillo, J
    Molina, CA
    Marti-Fabregas, J
    Blanco, M
    Mostacero, E
    Vivancos, J
    Roquer, J
    Escudero, D
    Chamorro, A
    Leira, R
    Tejero, C
    Montaner, J
    Serena, J
    [J]. STROKE, 2003, 34 (01) : 280 - 280
12345